» Authors » Katrien M J Devreese

Katrien M J Devreese

Explore the profile of Katrien M J Devreese including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 85
Citations 848
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Vandenheuvel M, Vierstraete L, De Somer F, Devreese K, Wouters P, De Kesel P
J Cardiothorac Vasc Anesth . 2025 Jan; PMID: 39890579
Objectives: The detection of low-range heparin activity is important to correctly assess heparin reversal and rebound, especially after cardiopulmonary bypass. Current parameters are either not available at point-of-care (anti-Xa activity...
2.
Devreese K, Bertolaccini M, Branch D, de Laat B, Erkan D, Favaloro E, et al.
J Thromb Haemost . 2024 Nov; 23(2):731-744. PMID: 39510414
Antiphospholipid syndrome (APS) diagnosis is dependent on the accurate detection and interpretation of antiphospholipid antibodies (aPL). Lupus anticoagulant (LA), anticardiolipin antibodies (aCL), and anti-beta2 glycoprotein I antibodies (aβ2GPI) remain the...
3.
4.
Duvillier L, Verhaege C, Devreese K, Gevaert S, Peperstraete H
Acta Cardiol . 2024 Oct; 79(7):805-812. PMID: 39377148
Background: Ticagrelor, used in acute coronary syndrome (ACS), can be administered via nasogastric tube when oral intake is impossible. We investigated platelet inhibition and pharmacokinetics in resuscitated ACS patients and...
5.
Devreese K
Semin Thromb Hemost . 2024 Oct; PMID: 39374845
Antiphospholipid syndrome (APS) diagnosis hinges on identifying antiphospholipid antibodies (aPL). Currently, laboratory testing encompasses lupus anticoagulant (LA), anticardiolipin (aCL), and anti-β2-glycoprotein I antibodies (aβ2GPI) IgG or IgM, which are included...
6.
Devreese K, Wahl D
Pol Arch Intern Med . 2024 Sep; 134(11). PMID: 39315882
This paper focuses on laboratory tests necessary for a diagnosis of antiphospholipid syndrome (APS). The diagnosis starts with a selection of patients suspected of APS. Timing related to a clinical...
7.
De Smet D, Hemelsoet D, De Herdt V, De Kesel P, Devreese K
Int J Lab Hematol . 2024 Aug; 46(6):1136-1139. PMID: 39176417
No abstract available.
8.
Barbhaiya M, Zuily S, Amigo M, Andrade D, Avcin T, Bertolaccini M, et al.
Arthritis Care Res (Hoboken) . 2024 Aug; 76(12):1617-1625. PMID: 39135467
Objective: The 2023 American College of Rheumatology/EULAR antiphospholipid syndrome (APS) classification criteria development, which aimed to identify patients with high likelihood of APS for research, employed a four-phase methodology. Phase...
9.
Vernemmen I, Buschmann E, Van Steenkiste G, Demeyere M, Verhaeghe L, De Somer F, et al.
J Vet Intern Med . 2024 Aug; 38(5):2707-2717. PMID: 39086137
Background: Cardiac catheterizations in horses are mainly performed in the right heart, as access to the left heart traditionally requires an arterial approach. Transseptal puncture (TSP) has been adapted for...
10.
Vandevelde A, Gris J, Moore G, Musial J, Zuily S, Wahl D, et al.
J Thromb Haemost . 2024 May; 22(8):2345-2362. PMID: 38704123
Background: Improving harmonization of the clinical interpretation of anticardiolipin (aCL) and anti-β2-glycoprotein I (aβ2GPI) antibodies immunoglobulin G (IgG)/immunoglobulin M (IgM) in the diagnosis of antiphospholipid syndrome (APS) is desirable. Likelihood...